P-059 Phase I trial of FOLFOXIRI in combination with Panitumumab as first-line treatment of RAS wild-type metastatic colorectal cancer (JACCRO CC-14)

Por Tsuji, A., Nakamura, M., Ogawa, M., Satake, H., Kotake, T., Hatachi, Y., Takagane, A., Okita, Y., Nakamura, K., Onikubo, T., Takeuchi, M., Fujii, M., Nakajima, T.
Publicado no Ann Oncol (2016)

Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis

Por Terashima, M, Maesawa, C, Oyama, K, Ohtani, S, Akiyama, Y, Ogasawara, S, Takagane, A, Saito, K, Masuda, T, Kanzaki, N, Matsuyama, S, Hoshino, Y, Kogure, M, Gotoh, M, Shirane, M, Mori, K
Publicado em 2005

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

Por Mochizuki, I, Takiuchi, H, Ikejiri, K, Nakamoto, Y, Kinugasa, Y, Takagane, A, Endo, T, Shinozaki, H, Takii, Y, Takahashi, Y, Mochizuki, H, Kotake, K, Kameoka, S, Takahashi, K, Watanabe, T, Watanabe, M, Boku, N, Tomita, N, Matsubara, Y, Sugihara, K
Publicado em 2012

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

Por Yoshida, M., Ishiguro, M., Ikejiri, K., Mochizuki, I., Nakamoto, Y., Kinugasa, Y., Takagane, A., Endo, T., Shinozaki, H., Takii, Y., Mochizuki, H., Kotake, K., Kameoka, S., Takahashi, K., Watanabe, T., Watanabe, M., Boku, N., Tomita, N., Nakatani, E., Sugihara, K.
Publicado em 2014